We are live on
!
Find out more
AAMU
Amundi Asset Management US Portfolio holdings
AUM
$131B
1-Year Est. Return
73.57%
This Fund
S&P 500
This Quarter
Est. Return
+14.66%
1 Year Est. Return
+73.57%
3 Year Est. Return
+96.88%
5 Year Est. Return
+179.37%
10 Year Est. Return
–
AUM
$71.1B
AUM Growth
-$37.5B
(-35%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
16.91%
Holding
1,740
New
147
Increased
556
Reduced
665
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$813M |
| 2 |
Amazon
AMZN
|
+$194M |
| 3 |
Progressive
PGR
|
+$180M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$165M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$479M |
| 2 |
Pfizer
PFE
|
+$254M |
| 3 |
Johnson & Johnson
JNJ
|
+$227M |
| 4 |
UnitedHealth
UNH
|
+$222M |
| 5 |
PepsiCo
PEP
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.97% |
| 2 | Healthcare | 14.37% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.82T
| $2.36B | 3.33% |
20,050,890
-4,394,308
| -18% | -$479M |
|
2
Apple
AAPL
$4.67T
| $1.93B | 2.71% |
40,622,340
+1,659,424
| +4% | +$70.4M |
|
|
3
Amazon
AMZN
$2.87T
| $1.22B | 1.72% |
13,749,740
+2,328,020
| +20% | +$194M |
|
|
4
PepsiCo
PEP
$192B
| $1.08B | 1.52% |
8,793,402
-1,558,410
| -15% | -$178M |
|
5
Home Depot
HD
$329B
| $1.05B | 1.48% |
5,473,637
-848,034
| -13% | -$156M |
|
6
Alphabet (Google) Class C
GOOG
$4.21T
| $990M | 1.39% |
16,875,660
-1,338,740
| -7% | -$75.1M |
|
|
7
Alphabet (Google) Class A
GOOGL
$4.25T
| $899M | 1.26% |
15,274,360
-2,617,140
| -15% | -$148M |
|
|
8
Linde
LIN
$225B
| $863M | 1.21% |
4,907,437
+4,892,828
| +33,492% | +$813M |
|
9
Alibaba
BABA
$295B
| $825M | 1.16% |
4,520,027
+393,477
| +10% | +$66.2M |
|
10
Mastercard
MA
$522B
| $797M | 1.12% |
3,383,867
-220,341
| -6% | -$47.4M |
|
11
AT&T
T
$178B
| $759M | 1.07% |
32,049,544
-4,009,944
| -11% | -$92.2M |
|
|
RTN
12
DELISTED
Raytheon Company
RTN
| $758M | 1.07% |
4,165,178
+284,688
| +7% | +$49.6M |
|
13
Medtronic
MDT
$117B
| $657M | 0.92% |
7,210,050
-518,330
| -7% | -$46.4M |
|
14
Merck
MRK
$366B
| $642M | 0.9% |
8,086,213
-1,543,489
| -16% | -$115M |
|
15
Eli Lilly
LLY
$1.04T
| $621M | 0.87% |
4,789,533
-1,223,289
| -20% | -$149M |
|
16
Visa
V
$713B
| $619M | 0.87% |
3,961,711
-105,247
| -3% | -$15.2M |
|
17
Intercontinental Exchange
ICE
$91.3B
| $609M | 0.86% |
7,996,464
-542,508
| -6% | -$40.6M |
|
18
Procter & Gamble
PG
$334B
| $605M | 0.85% |
5,817,043
-546,922
| -9% | -$53.2M |
|
19
Adobe
ADBE
$116B
| $600M | 0.84% |
2,252,031
-117,485
| -5% | -$29.6M |
|
20
Meta Platforms (Facebook)
META
$1.47T
| $574M | 0.81% |
3,443,314
-965,897
| -22% | -$154M |
|
21
Thermo Fisher Scientific
TMO
$230B
| $562M | 0.79% |
2,051,747
-191,604
| -9% | -$47.7M |
|
22
JPMorgan Chase
JPM
$949B
| $534M | 0.75% |
5,279,508
-1,263,389
| -19% | -$130M |
|
23
Bank of America
BAC
$436B
| $532M | 0.75% |
19,272,275
-2,731,127
| -12% | -$77.2M |
|
24
Accenture
ACN
$116B
| $524M | 0.74% |
2,975,932
-1,107,599
| -27% | -$174M |
|
|
25
Pfizer
PFE
$159B
| $523M | 0.74% |
12,991,983
-6,349,773
| -33% | -$254M |
|
Similar funds
WRF
SHP
SBSB
PAG
BUB
OP
PPCM
AAM
Amundi Asset Management US's Q1 2019 Portfolio in Review
As of Q1 2019, Amundi Asset Management US held 1,740 positions worth $71.1B, down 35% from $109B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Amundi Asset Management US withdrew a net $3.97B in Q1 2019, closing 111 positions and reducing 665 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $29.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Amundi Asset Management US opened a new position in Novo Nordisk worth $49M.
- Amundi Asset Management US's largest Q1 2019 buy was Novo Nordisk: 1,874,924 shares worth $49M.
- Amundi Asset Management US added most to Linde in Q1 2019, an estimated $813M increase.
- Amundi Asset Management US's biggest Q1 2019 reduction was Microsoft, cutting an estimated $479M.
- Amundi Asset Management US fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $29.3M.
- Amundi Asset Management US's ten largest holdings make up 17% of its $71.1B portfolio in Q1 2019.
- Amundi Asset Management US opened 147 new positions and closed 111 in Q1 2019.
- Amundi Asset Management US's portfolio value fell 35% quarter-over-quarter to $71.1B.
Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.